{
    "Trade/Device Name(s)": [
        "ADVIA Centaur Intact Parathyroid Hormone (PTH) Assay",
        "ADVIA Centaur\u00ae Intact Parathyroid Hormone (PTH)"
    ],
    "Submitter Information": "Siemens Healthcare Diagnostics Inc.",
    "510(k) Number": "K163658",
    "Predicate Device Reference 510(k) Number(s)": [
        "K133601"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CEW"
    ],
    "Summary Letter Date": "April 24, 2017",
    "Summary Letter Received Date": "April 25, 2017",
    "Submission Date": "May 22, 2017",
    "Regulation Number(s)": [
        "21 CFR 862.1545"
    ],
    "Regulation Name(s)": [
        "Parathyroid hormone test system"
    ],
    "Analyte Class(es)": [
        "endocrine",
        "chemistry"
    ],
    "Analyte(s)": [
        "Intact parathyroid hormone (PTH)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Serum red top tube",
        "Serum separator tube (SST)",
        "EDTA tube",
        "Lithium heparin tube",
        "Sodium heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "ADVIA Centaur XP system"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescence",
        "Sandwich immunoassay"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Calibrator"
    ],
    "Document Summary": "FDA 510(k) summary for ADVIA Centaur Intact Parathyroid Hormone (PTH) assay utilizing chemiluminescent sandwich immunoassay for quantitative measurement of intact parathyroid hormone in serum and plasma",
    "Indications for Use Summary": "In vitro diagnostic assay for quantitative determination of intact parathyroid hormone (PTH) in human serum and plasma, aiding in the differential diagnosis of hyperparathyroidism, hypoparathyroidism, or disorders of calcium metabolism, and usable intra-operatively.",
    "fda_folder": "Clinical Chemistry"
}